• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season

tetano

Editor, Senior Moderator
Protein Eng Des Sel. 2016 Jun 16. pii: gzw017. [Epub ahead of print]
[h=1]Influenza evolution and H3N2 vaccine effectiveness, with application to the 2014/2015 season.[/h] Li X[SUP]1[/SUP], Deem MW[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza A is a serious disease that causes significant morbidity and mortality, and vaccines against the seasonal influenza disease are of variable effectiveness. In this article, we discuss the use of the p[SUB]epitope[/SUB] method to predict the dominant influenza strain and the expected vaccine effectiveness in the coming flu season. We illustrate how the effectiveness of the 2014/2015 A/Texas/50/2012 [clade 3C.1] vaccine against the A/California/02/2014 [clade 3C.3a] strain that emerged in the population can be estimated via p[SUB]epitope[/SUB] In addition, we show by a multidimensional scaling analysis of data collected through 2014, the emergence of a new A/New Mexico/11/2014-like cluster [clade 3C.2a] that is immunologically distinct from the A/California/02/2014-like strains.
? The Author 2016. Published by Oxford University Press.


[h=4]KEYWORDS:[/h] dominant strains; influenza evolution; pepitope; phylogeny; vaccine effectiveness

PMID: 27313229 [PubMed - as supplied by publisher] Free full text
 
Back
Top Bottom